Related Experiment Videos

Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene

Insights

The Ha-ras gene product p21, similar to guanine nucleotide-binding proteins, regulates adenylate cyclase. EJ-ras oncogene expression significantly reduces hormone-stimulated adenylate cyclase activity in NIH-3T3 cells.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncology

Background:

  • The 21-kilodalton protein (p21) Ha-ras gene product shows homology with mammalian guanine nucleotide-binding proteins.
  • This suggests p21 may regulate adenylate cyclase activity in vertebrate cells.

Purpose of the Study:

  • To investigate the role of Ha-ras p21 in regulating adenylate cyclase activity.
  • To determine the effect of EJ-ras oncogene expression on hormone-stimulated adenylate cyclase.

Main Methods:

  • Assessing adenylate cyclase activity in intact and membrane preparations of NIH-3T3 murine cells.
  • Measuring cyclic AMP (cAMP) levels via radioimmunoassay following prostaglandin and isoproterenol stimulation.
  • Evaluating the impact of pertussis toxin and cholera toxin treatments.

Main Results:

  • EJ-ras transformed cells exhibited significantly reduced adenylate cyclase activity (78-93% decrease) compared to control cells.
  • Cells expressing normal Ha-ras showed intermediate adenylate cyclase sensitivity.
  • Toxin treatments did not restore normal adenylate cyclase activity in EJ-ras cells.

Conclusions:

  • Ha-ras p21, both normal and mutated forms, is implicated in regulating guanine nucleotide-binding proteins.
  • EJ-ras oncogene expression disrupts normal adenylate cyclase regulation, impacting cAMP signaling pathways.

Related Concept Videos